Parkinson's UK (Venture Fund)

This organisation operates as a specialised global programme to accelerate transformative treatments. It acts as an investor with the expertise to monitor and manage drug development projects. The initiative provides early-stage funding to high-potential pre-clinical and clinical programs. By funding critical milestones, it decreases the risk profile of novel assets for downstream participation. It invests in drug discovery and clinical trials to drive forward better disease-modifying and symptomatic treatments.